ban semaglutide fda bans compounded and tirzepatide on The End of Compounded Semaglutide: Why the FDA's Decision Matters for is fda stopping compounded tirzepatide – Compounded Semaglutide Ban Status &

We expect net pricing declines to continue to occur over time, but list price adjustments are unlikely to significantly impact the rate of these net price declines. Novos latest price cut follows Mondays news that the Danish pharmas next-generation obesity candidate CagriSema lost to Zepbound in a head-to-head trial initiated by Novo

Chinese medical journal

One study has indicated that after 16 weeks of treatment, on average, people lose 5.7% of their body weight and a separate study has shown that after a period of 68 weeks, there is an average of 15% of body weight lost

Patients reporting "significant energy improvement" rate injections as worth the cost at 2.4x the rate of those reporting "mild improvement." Comparison to alternatives: MIC B12 injections occupy a middle ground: more effective than oral supplementation for B12 repletion and subjective energy, less effective than prescription weight-loss medications for weight reduction, and significantly less expensive than GLP-1 agonists

PapiAAlfanoFBigoniTManciniLMawassABaraldiFet al